Division of Pediatric Pulmonology and Allergy, University of Maryland, Baltimore, Maryland, USA.
Ann Allergy Asthma Immunol. 2013 Sep;111(3):185-9. doi: 10.1016/j.anai.2013.06.009. Epub 2013 Jul 21.
Children with asthma receiving specialty care have been found to have improved asthma outcomes. However, these outcomes can be adversely affected by poor adherence with controller medications.
To analyze pharmacy fill patterns as a measure of primary adherence in a group of underserved minority children receiving allergy subspecialty care.
As part of a larger 18-month nebulizer use study in underserved children (ages 2-8 years) with persistent asthma, 53 children were recruited from an urban allergy practice. Pharmacy records were compared with prescribing records for all asthma medications.
Allergist controller prescriptions were written in 30-day quantities with refills and short-acting β-agonists (SABAs) with no refills. Only 49.1% of inhaled corticosteroid (ICS), 49.5% of combination ICS and long-acting β-agonist, and 64.5% of leukotriene modifier (LTM) initial and refill prescriptions were ever filled during the 18-month period. A mean of 5.1 refills (range, 0-14) for SABAs were obtained during 18 months, although only 1.28 SABA prescriptions were prescribed by the allergist. Mean times between first asthma prescription and actual filling were 30 days (range, 0-177 days) for ICSs, 26.6 days (range, 0-156 days) for LTMs, and 16.8 days (range, 0-139 days) for SABAs.
Underserved children with asthma receiving allergy subspecialty care suboptimally filled controller prescriptions, yet filled abundant rescue medications from other prescribers. Limiting albuterol prescriptions to one canister without additional refills may provide an opportunity to monitor fill rates of both rescue and controller medications and provide education to patients about appropriate use of medications to improve adherence.
接受专科护理的哮喘儿童的哮喘结果已得到改善。然而,这些结果可能会因对控制器药物的依从性差而受到不利影响。
分析药剂填充模式作为衡量接受过敏专科护理的服务不足少数族裔儿童初级依从性的指标。
作为一项针对患有持续性哮喘的服务不足儿童(2-8 岁)使用雾化器的为期 18 个月的研究的一部分,从一家城市过敏诊所招募了 53 名儿童。将药房记录与所有哮喘药物的处方记录进行比较。
过敏症专家开出的控制器处方为 30 天用量,并可续方;短效 β-激动剂(SABA)则不可续方。在 18 个月期间,仅 49.1%的吸入皮质类固醇(ICS)、49.5%的联合 ICS 和长效β-激动剂以及 64.5%的白三烯调节剂(LTM)初始和续方处方得到了填充。在 18 个月期间,平均获得了 5.1 次 SABA 的续方(范围 0-14 次),尽管过敏症专家仅开出了 1.28 次 SABA 处方。首次开具哮喘处方和实际用药之间的平均时间间隔为 ICS 为 30 天(范围 0-177 天)、LTM 为 26.6 天(范围 0-156 天)和 SABA 为 16.8 天(范围 0-139 天)。
接受过敏专科护理的服务不足的哮喘儿童对控制器处方的填充不理想,但从其他处方医生处获得了大量的急救药物。限制沙丁胺醇的处方为一个小瓶且不可续方,这可能为监测急救和控制器药物的填充率并向患者提供有关适当使用药物以提高依从性的教育提供了机会。